The PSA Controversy

Over the last few days the media has been full of debate about the most recent, contradictory studies that have been released about the efficacy of the PSA as a diagnostic tool for prostate cancer. Normally, I would not write about this issue in this blog since those of us with recurrences and advanced prostate [...]

FDA Warns About Risk of Wearing Medicated Patches During an MRI

The FDA has issued an emergency warning that certain adhesive patches (transdermal patches) that deliver medication through the skin have been found to be a risk to patients safety while they undergo a magnetic resonance imaging (MRI). If these problem patches are affixed to the skin while actually undergoing the scan they can cause skin [...]

Proper Warfarin Dosing – Using Genetics

One of the significant secondary side effects resulting from of our advanced prostate cancer treatments can be blood clots. Blood clots are potentially dangerous as they can lead to heart attacks, strokes and death. Warfarin is one of the drugs commonly prescribed to prevent these dangerous blood clots from ever forming. However, dosing of Warfarin [...]

What is the Role of the Circulating Cancer Cell Test in the Treatment of Advanced Prostate Cancer?

A relatively new arrival on the cancer scene is a test called the circulating cancer cell test. Many of the major labs and hospital cancer cells are able to run the test, including Quest Diagnostics, which has named this test as the Cell Search test. Just like the PSA test, it is a blood test. [...]

Can the “Right to Die” Become A “Duty to Die”

Wesley Smith who is a lawyer, associate director of the International Task Force on Euthanasia and Assisted Suicide and senior fellow at the Discovery Institute has published an article in the Telegraph of the experience of Oregon and its "assisted suicide" law. "Imagine that you have lung (or prostate cancer, I know it is rare, [...]

The Partnership for Prescription Assistance

How can you obtain financial assistance getting your prescription drugs? One possible solution is the Partnership for Prescription Assistance. from their web site: "The Partnership for Prescription Assistance brings together America's pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines [...]

Scott Goodwin Reports in with Some Encouraging News

Scott has been graciously reporting on his experience undergoing chemotherapy in this blog. You can see his prior posts by searching by his name. On his last report he shared that he was going to take an unorthodox step, stopping his hormone blockade when on chemo. Normally, when chemotherapy is used to treat advanced prostate [...]

Algeta, Completing A Successful Phase II Trial For Men With Bone Metastases Will Begin Enrolling US Survivors Into A Phase III Trial

Algeta ASA (OSE: ALGETA), has announced that it will begin to enroll US survivors into its Alsympca phase III trial evaluating Alpharadin (radium-223). Alpharadin is designed to be used as a treatment for bone metastases in prostate cancer survivors with hormone-refractory prostate cancer (HRPC). The announcement of the trial follows a successful end-of-phase II meeting [...]

Who Should Become the New FDA Commissioner?

The Food and Drug Administration (FDA) is one of the major governmental entities that has a significant, direct and immediate affect on any of us who has any illness. All men with prostate cancer have had their life and their deaths impacted by the FDA. This impact has not been on just a few of [...]

Go to Top